Kind Pharmaceuticals LLC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 in Phase 3

Quick facts

Phase 3 pipeline

AND017 · Diabetes
AND017 is a small molecule that targets the SGLT2 receptor.

Phase 2 pipeline

AND017 capsules
AND017 capsules QW · Diabetes
AND017 capsules QW is a small molecule that targets the SGLT2 receptor.
AND017 capsules TIW

Phase 1 pipeline

AND017 multiple dose
AND017 single dose
AND019 PO QD

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Kind Pharmaceuticals LLC portfolio CI brief
Kind Pharmaceuticals LLC pipeline updates RSS

Frequently asked questions about Kind Pharmaceuticals LLC

What is Kind Pharmaceuticals LLC's pipeline?

Kind Pharmaceuticals LLC has 1 drugs in Phase 3, 3 in Phase 2, 3 in Phase 1. Late-stage candidates include AND017.

Sector hub: All tracked pharma companies